Abstract
The noradrenergic (NA) projections arising from the locus ceruleus (LC) to the amygdala and bed nucleus of the stria terminalis have been implicated in the formation of emotional memory. Since NA neurons in the LC (LC-NA neurons) abundantly express orexin receptor-1 (OX1R) and receive prominent innervation by orexin-producing neurons, we hypothesized that an OX1R-mediated pathway is involved in the physiological fear learning process via regulation of LC-NA neurons. To evaluate this hypothesis, we examined the phenotype of Ox1r−/− mice in the classic cued and contextual fear-conditioning test. We found that Ox1r−/− mice showed impaired freezing responses in both cued and contextual fear-conditioning paradigms. In contrast, Ox2r−/− mice showed normal freezing behavior in the cued fear-conditioning test, while they exhibited shorter freezing time in the contextual fear-conditioning test. Double immunolabeling of Fos and tyrosine hydroxylase showed that double-positive LC-NA neurons after test sessions of both cued and contextual stimuli were significantly fewer in Ox1r−/− mice. AAV-mediated expression of OX1R in LC-NA neurons in Ox1r−/− mice restored the freezing behavior to the auditory cue to a comparable level to that in wild-type mice in the test session. Decreased freezing time during the contextual fear test was not affected by restoring OX1R expression in LC-NA neurons. These observations support the hypothesis that the orexin system modulates the formation and expression of fear memory via OX1R in multiple pathways. Especially, OX1R in LC-NA neurons plays an important role in cue-dependent fear memory formation and/or retrieval.
Introduction
Orexins (Sakurai et al., 1998) are implicated in regulation of sleep/wakefulness, energy homeostasis, and the reward system (Sakurai, 2007; Sakurai and Mieda, 2011). Orexin-immunoreactive fibers are observed in almost the entire neuraxis (Peyron et al., 1998; Date et al., 1999; Nambu et al., 1999), with especially dense fibers in monoaminergic nuclei in the brainstem (Date et al., 1999; Nambu et al., 1999; Peyron et al., 2000). The distribution of the two orexin receptors is consistent with these projection sites (Marcus et al., 2001).
It has been thought that orexin-2 receptor (OX2R) plays a pivotal role in sleep–wake regulation (Hondo et al., 2010; Sakurai and Mieda, 2011). Metabolic and feeding regulation by orexins is also suggested to be regulated through an OX2R-mediated pathway (Funato et al., 2009). However, very limited information is available regarding the physiological role of the orexin-1 receptor (OX1R).
OX1R is abundantly expressed in the locus ceruleus (LC), which plays important roles in many functions via its widespread projections (Bailey et al., 2000; McGaugh and Roozendaal, 2002). The LC contains tyrosine hydroxylase (TH)-positive noradrenergic (NA) neurons. Because orexin neurons send rich projections to the LC, and OX1R is expressed in Vmat2-positive neurons in the LC (Mieda et al., 2011), the physiological function of OX1R might be closely related to the function of NA neurons in the LC (LC-NA neurons). Consistently, orexin potently excited LC-NA neurons (van den Pol et al., 2002).
There is much evidence suggesting the importance of the NA system in emotional memory formation. Conditioned fear stress caused a robust increase in the firing rate of NA neurons (Chen and Sara, 2007) and induced Fos expression in the LC (Ishida et al., 2002). LC-NA neurons project to the lateral amygdala (LA), an important structure for emotional memory (Bush et al., 2010). These observations suggest that NA input from the LC to the LA is one of the key factors in fear memory formation.
Orexin neurons receive input from the limbic system (Winsky-Sommerer et al., 2004; Sakurai et al., 2005; Yoshida et al., 2006). These observations raise the possibility that orexin neurons may be activated by emotional information transmitted from the amygdala, and in turn send excitatory output to the LC, and this connection plays an important role in modulating emotional memory.
We found here that Ox1r−/− mice showed decreased freezing behavior to both cued and contextual stimuli during both the conditioning and test periods, suggesting that OX1R is involved in evoking fear-related behavior. In contrast, Ox2r−/− mice responded normally with freezing behavior in the cued fear-conditioning test. We also found that Fos expression in LC-NA neurons after exposure to the fearful context was significantly lower in Ox1r−/− mice than in wild-type mice. Importantly, we found that freezing behavior recovered to a level comparable to that in wild-type mice in the test period of cued fear conditioning when OX1R expression in LC-NA neurons was restored, suggesting that OX1R-mediated regulation of LC-NA neurons plays a significant role in the acquisition and consolidation of cue-dependent fear memory.
Materials and Methods
Animals.
All experimental procedures were approved by the Animal Experiment and Use Committee of Kanazawa University (AP-111947), and were thus in accordance with National Institutes of Health guidelines. We used Ox1r−/− mice in which the Ox1r-coding region in exon 1 of the Ox1r gene is disrupted by inserting a tau-LacZ cassette (Hondo et al., 2010). Ox1r−/− mice used in the experiments were obtained from the mating of heterozygous Ox1r+/− mice. Ox2r−/− mice were previously reported (Willie et al., 2003). Exon 1 of the Ox2r gene was replaced in-frame with the nlacZ cassette. Ox2r−/− mice used in the experiments were obtained from the mating of heterozygous Ox2r+/− mice. Genotyping these mice was done by PCRs with tail DNA according to the method described previously (Willie et al., 2003). These mice were backcrossed to wild-type C57BL/6J mice for >10 generations. Their littermates of each genotype were used as wild-type control. Mice were maintained under a strict 12 h light/dark cycle in a temperature- and humidity-controlled room and fed ad libitum.
Behavioral experiments.
All experiments were performed during the light phase (13:00–16:00) using male 12- to 14-week-old mice. Before the experiments, these mice were isolated for 2 weeks. The experimenters were blinded to the genotypes until all data had been gathered and analyzed. Behavioral experiments in this study were basically performed according to modifications of previously described protocols (Miyakawa et al., 2003). The behavior of mice was recorded using a charge coupled device video camera and analyzed with a video-tracking system CompACT VAS version 3.0x (Muromachi Kikai). For the cued fear-conditioning test, mice were placed in a conditioning chamber (15 × 12 × 13 cm, acrylic walls with a gridded floor and bright lighting) for 90 s before giving a conditioned stimulus (CS), a 2900 Hz, 80 dB tone that lasted 30 s immediately, followed by the presentation of an unconditioned stimulus (US), a mild foot shock of 0.3 mA for 2 s, on the training day. Five consecutive trials of training were performed (see Fig. 1A). After an additional stay for 90 s in the chamber, the mouse was returned to its home cage. Mice were tested 24 h after the training. Cued fear test was conducted in a chamber with a different context (13 × 20 × 11 cm, a plastic cage surrounded with a white screen and bright lighting). Freezing behavior was scored during the testing session. Freezing behavior is defined as the complete absence of any movement except for respiration and heartbeat. Freezing behavior is measured by an automated scoring system (Muromachi Kikai), which recognizes complete absence of movement lasting for longer than 2 s as freezing. Testing was performed with the same procedure as in the conditioning period, but without application of US (Fig. 1A).
For the contextual fear-conditioning test, mice were placed in the conditioning chamber for 90 s before giving a US, a mild foot shock of 0.3 mA for 2 s, on the training day. Five sequential foot shocks at 90 s intervals were applied. The mice were tested 24 h after the conditioning. They were put in the same conditioning chamber for 5 min without presentation of CS (see Fig. 2A). We used different mice for the cued test and contextual test. Data are presented as mean ± SEM. The apparatus was cleaned with 30% ethanol solution, and then with water and dried after each trial to eliminate possible odor cues left by previous subjects.
To measure the ultrasonic vocalizations of mice, we used an ultrasonic vocalization (USV) analyzer (Muromachi Kikai), following the manufacturer's instructions.
Construction of recombinant adeno-associated virus vectors.
The common structure of the adeno-associated virus (AAV)-2 ITR-containing plasmids used in this study is ITR-promoter-cDNA encoding a protein-WPRE-poly (A)+ signal-ITR. cDNA encoding rat Ox1r fused with EYFP at the C terminal was inserted downstream of the PRSx8 promoter (AAV-PRSx8-OX1R-EYFP; see Fig. 4A) (Hwang et al., 2001). We used AAV with PRSx8 promoter carrying ChR2 (NA-ChR2) for the control group (AAV-PRSx8-ChR2-EYFP; Fig. 4A), because ChR2 has a similar seven transmembrane structure to that of OX1R. AAV-2 vectors with a mutant form of the cap gene (Zhong et al., 2008) were produced using a triple-transfection, helper-free method, and purified as described previously (Sasaki et al., 2011). In brief, 293A cells (Invitrogen), cultured in 10 100 × 20 mm cell culture dishes per viral vector, were transfected with pHelper (Stratagene), pACG-2-Y730F (containing a mutant form of the cap gene of AAV2, provided by Dr. Arun Srivastava of the University of Florida), and pAAV-PRSx8-OX1R-EYFP or pAAV-PRSx8-ChR2-EYFP, using a standard calcium phosphate method. Three days later, the cells were collected, pelleted, and resuspended in freezing buffer (10 ml of 0.15 m NaCl, 50 mm Tris, pH 8.0). After two freeze–thaw cycles and subsequent centrifugation, each lysate was treated with DNase I (40 μg/ml) and RNase A (40 μg/ml) and then with deoxycholic acid (Sigma; 0.5%), followed by filtration. Each cleared lysate was mixed with 1.5 ml heparin-agarose suspension (Sigma) equilibrated with freezing buffer, incubated with gentle rotation for 60 min at 4°C, and loaded onto a Bio-Spin Column 100 (Bio-Rad). Each column was washed three times with 2 ml freezing buffer, and viruses were eluted with 3 ml elution buffer (0.5 m NaCl, 50 mm Tris, pH 8.0). Each virus preparation was dialyzed against 1× PBS using Slide-A-Lyzer Dialysis Cassettes (Pierce) and concentrated using Concentration Solution (Pierce). The final purified viruses were stored at −80°C. A detailed description and characterization of these viruses will also be published (E. Hasegawa, T. Sakurai, and M. Mieda., unpublished results). The titers of recombinant AAV vectors were as follows: AAV-PRSx8-ChR2-EYFP; 5.0 × 1012, AAV-PRSx8-OX1R-EYFP; 8.4 × 1011 genome copies/ml.
Virus injection.
Ox1r−/− mice (12 weeks old) were anesthetized with sodium pentobarbital (Nembutal 50–60 mg/kg, i.p.) and positioned in a stereotaxic frame (David Kopf Instruments). After drilling into the skull of each mouse at sites (anteroposterior, −5.4 mm; mediolateral, ±0.9 mm; dorsoventral, 3.7 mm), a Hamilton needle syringe (33 gauge) was placed in each site, and 1 μl of purified virus was delivered over a 20 min period. At 14 d after injection, mice were subjected to behavioral experiments, and then killed and brain samples were examined by immunohistochemical staining. Behavioral data were only included if OX1R was precisely targeted to the LC-NA neurons.
Fos immunohistochemistry.
Mice were deeply anesthetized with sodium pentobarbital and then fixed by intracardiac perfusion with 4% paraformaldehyde 90 min after cued or contextual fear tests. Then, the brain was postfixed for 24 h in the same fixative and cryoprotected by immersion in 30% sucrose for 2 d. Brain sections of 30 μm thickness were cut with a cryostat. Sections were washed and blocked with 0.1 m PBS containing 0.25% Triton X-100 plus 3% bovine serum albumin (BSA). Then, slices were incubated with the designated primary antibodies in PBS overnight at 4°C. Antibodies used in this study were rabbit polyclonal antibody against c-Fos (1:5000, Ab-5; Millipore), mouse polyclonal antibody against tyrosine hydroxylase (TH) (1:2500, F-11; Santa Cruz Biotechnology), and goat antibody against green fluorescent protein (GFP; 1:1000; Molecular Probe). Then, slices were washed with PBS three times, followed by incubation with the designated secondary antibodies in PBS for 2.5 h. Secondary antibodies used in this study were Alexa 594-conjugated donkey anti-rabbit IgG, Alexa 594-conjugated donkey anti-mouse IgG, Alexa 488-conjugated donkey anti-mouse IgG, and Alexa 488-conjugated donkey anti-rabbit IgG (1:1000; Invitrogen). Slices were washed three times in PBS, mounted on subbed slides, air dried, and coverslipped using FluorSave Reagent (Calbiochem). The numbers of Fos-positive and Fos-negative NA neurons were counted in every coronal section throughout the LC by a single examiner who was blinded to the genotype of mice, using images taken with a confocal laser-scanning microscope FV10i (Olympus). Cells were counted on both sides of the brain in four consecutive 30 μm sections. Activity of NA neurons was scored as the percentage of double-labeled cells per animal.
To assess amygdala activity, we detected for Zif268 immunoreactivity in the lateral region of the amygdala. Coronal sections of brains were incubated for 35 min in 0.6% hydrogen peroxide to eliminate endogenous peroxide activity. Sections were rinsed in PBS and incubated for 30 min in Tris-buffered saline (TBS) containing 3% goat serum and 0.25% Triton X-100. Thereafter, sections were incubated overnight with rabbit anti-Egr-1 (Zif268) antibody (C-19; Santa Cruz Biotechnology) in TBS containing 3% BSA and 0.25% Triton X-100. The primary antibody was localized with the avidin–biotin system (Vector Laboratories). Zif268-positive neurons were counted in coronal sections throughout the LA region by a single examiner who was blinded to the treatment conditions, using a Keyence BZ-9000 microscope. The region of interest was designated as previously described (Díaz-Mataix et al., 2013). Cells were counted on both sides of the brain in consecutive 40 μm sections throughout the LA using ImageJ 1.46r software (http://rsbweb.nih.gov/ij/).
Statistical analysis.
Data were expressed as mean ± SEM. Two-way ANOVA followed by Bonferroni correction as a post hoc test or Student's t test using GraphPad Prism 5.0b was used for comparison among the various treatment groups. Differences were considered significant at p < 0.05.
Results
Differential roles of OX1R and OX2R in cued and contextual fear conditioning
To evaluate the possibility that OX1R-mediated pathways are involved in presentation of fear-related behavior and/or fear memory formation/acquisition, we tested Ox1r−/− mice and Ox2r−/− mice in cued and contextual fear-conditioning tests. Schematic representations of the training and testing protocols of these fear-conditioning paradigms are shown in Figures 1A and 2A.
Ox1r−/− mice displayed a significant decrease of evoked freezing behavior during both cued and contextual fear tests compared with wild-type littermates, while Ox2r−/− mice showed a decreased freezing response only in the contextual test (Figs. 1D, 2D). In the cued fear conditioning, these mice already showed significant impairment of freezing behavior in the conditioning period (F(1,29) = 9.50; p = 0.0045), while Ox2r−/− mice also showed a tendency for a shorter freezing time, although it did not reach significance (F(1,28) = 4.00; p = 0.0552; Fig. 1B). In the conditioning session, although all groups showed a gradual increase in freezing time in response to CS paired with US, Ox1r−/− mice showed a significantly shorter freezing time in each epoch. In the cued test period, Ox1r−/− mice also showed a significantly shorter freezing time in the periods of both presence and absence of CS compared with wild-type mice (F(1,29) = 7.88, p = 0.0088; Fig. 1C,D).
The intensity of the freezing response shown after shock delivery is also related to the level of sensory perception of mice. We examined the sensory perception function of Ox1r−/− and control mice by measuring USVs of these mice against various intensity of foot shock (US) and found that the threshold intensity of US to evoke USVs was not different between genotypes (WT 0.07 ± 0.0065 mA, Ox1r−/− 0.06 ± 0.0067 mA, n = 8 each, p = 0.6004). The frequency and amplitude of USVs evoked by the foot shock were also not different between genotypes (WT 58.6 ± 3.34 dB, 24433.6 ± 3040 Hz; Ox1r−/− 59.0 ± 2.66 dB, 25570.3 ± 2460 Hz, p = 0.9151 and 0.7756, respectively). This result excludes the possibility that Ox1r−/− mice exhibit a decreased response to foot shock due to decreased sensitivity to US.
In the contextual fear-conditioning test, there was a significant difference between Ox1r−/− (n = 17) and wild-type (n = 19) mice during the conditioning period (F(1,34) = 9.09; p = 0.0048). Also, there was a significant difference between Ox2r−/− mice (n = 15) and wild-type mice (F(1,30) = 4.30; p = 0.0467; Fig. 2B). During the test session, there was significant impairment of freezing duration in both Ox1r−/− (F(1,34) = 7.92; p = 0.0081) and Ox2r−/− mice (F(1,30) = 11.25; p = 0.0022) compared with wild-type mice (Fig. 2C). The degree of impairment in Ox1r−/− mice compared with wild-type mice was larger in the test session than in the conditioning period. These results suggest that the decrease of freezing behavior in Ox1r−/− mice is due to abnormalities both in the mechanisms that evoke fear-related behavior itself and in the formation of fear memory. While Ox1r−/− mice showed decreased freezing behavior in both the cued and contextual fear-conditioning tests, Ox2r−/− mice showed impairment only in the contextual fear-conditioning test (Figs. 1, 2). This suggests that OX1R is involved in both cued fear conditioning and contextual fear conditioning, while OX2R plays a role only in contextual fear conditioning.
Impaired response of LC-NA neurons of Ox1r−/− mice after exposure to fearful situations
Since OX1R is most abundantly expressed in the LC, we examined the activity of NA neurons in the LC, in which the largest source of NA neurons in the brain is located. In this experiment, we examined Fos expression in LC-NA neurons after each session of cued and contextual fear paradigms (Fig. 3). Mice were killed 90 min after the conditioning or test and their brains were subjected to analysis. Double-labeling immunofluorescence analysis with TH and Fos antibodies revealed that the number of Fos-positive LC-NA neurons was very low and comparable in both genotypes in the naive condition (Fig. 3B). After the cued or contextual conditioning, the number was increased in both genotypes. However, Ox1r−/− mice showed a significantly lower number of double-labeled cells in the LC compared with wild-type after both cued and contextual conditioning (Fig. 3C,E). The number of double-positive cells was also increased after the test sessions compared with basal conditions, but Ox1r−/− mice again showed a lower response compared with wild-type (Fig. 3D,F). These observations suggest that an OX1R-mediated pathway activates LC-NA neurons in emotionally relevant situations.
Restoration of OX1R expression in LC-NA neurons normalized cued fear behavior in Ox1r−/− mice
We found that Ox1r−/− mice showed lower activity of LC-NA neurons after cued or contextual fear-conditioning and tests (Fig. 3). This suggests that OX1R-mediated activation of LC might play a role in fear memory or fear response. We next examined whether LC-NA neuron-specific restoration of OX1R expression in the LC could affect freezing behavior.
To express OX1R specifically in NA neurons in the LC, we used an AAV vector with the PRSx8 promoter, which directs expression of designated genes specifically in NA neurons. To examine the specific expression in NA neurons, we confirmed the injection sites and expression of OX1R with double-labeling immunofluorescence analysis with anti-TH and anti-GFP antibodies. GFP was specifically observed in TH-positive cells (70.43 ± 15.62% of GFP-positive neurons were TH positive, N = 29) in the LC (Fig. 4B). We only included the behavioral data if the injection was achieved precisely in the LC bilaterally and >10% of TH-positive cells expressed GFP.
For the cued fear-conditioning test, we found that Ox1r−/− mice with LC-NA neuron-specific expression of OX1R (KO-OX1R group) did not show any difference in freezing time in the conditioning session in the presence or absence of CS, compared with the control group (Ox1r−/− mice with expression of ChR2 in LC-NA neurons, KO-ChR2 group) (F(1,13) = 0.09, p = 0.7636; Fig. 4C). However, the KO-OX1R group showed freezing behavior with a level comparable to that in wild-type controls in the test session (F(1,13) = 1.52; p = 0.2394; Fig. 4D). Although both groups showed a significant increase of freezing times in response to CS presentation, the KO-OX1R group showed an increase of freezing time in the test period to a level comparable to that in wild-type mice, especially in the presence of CS, with a longer freezing time compared with that in the KO-ChR2 group (t = 2.243, p = 0.0430; Fig. 4E). These observations suggest that OX1R in LC-NA neurons does not play a major role in the emergence of fear-related behavior in unconditioned situations, but is likely to play an important role in consolidation, retrieval, and presentation of cue-dependent fear memory (Fig. 4E).
AAV-mediated expression of OX1R in LC-NA neurons in wild-type mice (WT-OX1R) showed no difference in freezing response in both cued and contextual fear conditioning and testing compared with wild-type mice (data not shown; Fig. 4E).
Conversely, in the contextual fear-conditioning test, we did not find any difference between the KO-OX1R and KO-ChR2 groups during both the conditioning and test periods (F(1,12) = 0.02; p = 0.8964; F(1,12) = 0.03; p = 0.8711, respectively; Fig. 4F–H). The KO-OX1R group showed significantly less freezing behavior during both the conditioning and test periods compared with wild-type (F(1,22) = 3.97; p = 0.0325; F(1,22) = 4.73; p = 0.0407, respectively). These results suggest that restoration of OX1R expression in the LC is not sufficient to rescue the formation of fear memory of contextual information. Restoration of OX1R expression in LC-NA neurons also did not affect freezing behavior during the contextual conditioning session, suggesting that the mechanisms of emergence of a behavioral response to unconditioned threats do not depend on OX1R in LC-NA neurons, but rather involve OX1R in other brain region(s).
OX1R in LC-NA neurons plays an important role in activation of the amygdala during fearful situations
To investigate whether OX1R in LC-NA neurons is involved in activation of the amygdala in fearful situations, we tracked the level of zif268 (Egr-1) protein expression in the LA. We analyzed zif268 expression in mice after cued or contextual fear tests. No difference was found in the level of zif268 in the LA between genotypes in a naive condition (WT; n = 5, Ox1r−/−; n = 5, p = 0.1980; Fig. 5B). After cued or contextual tests, Ox1r−/− mice showed fewer zif268-positive cells in the LA after cued test (Fig. 5C) (WT; n = 4, Ox1r−/−; n = 5, p = 0.0068). We also observed a similar tendency in the contextual test, but the difference did not reach significance (Fig. 5D) (WT; n = 5, Ox1r−/−; n = 5, p = 0.0684).
Furthermore, rescue of OX1R in LC-NA neurons in Ox1r−/− mice increased Fos expression in the LC (KO-ChR2; n = 5, KO-OX1R; n = 5, t = 2.744, p = 0.0253) and zif268 protein in the LA after cued testing, to levels comparable to those in wild-type mice (KO-ChR2; n = 5, KO-OX1R; n = 6, t = 2.861, p = 0.0187; Fig. 6B,C). In contrast, ChR2 expression did not show an effect. OX1R rescue in LC-NA neurons did not normalize zif268 protein expression after the contextual test (n = 5 each, t = 0.5429, p = 0.6020), although it increased the number of Fos-positive TH neurons in the LC (KO-ChR2; n = 5, KO-OX1R; n = 4, t = 3.512, p = 0.0098; Fig. 6D,E). These observations suggest that OX1R in LC-NA neurons plays an important role in activation of the amygdala in response to an explicit cue, presumably through NA projections to the amygdala. However, this system is not sufficient to lead to amygdala activation in response to emotionally relevant contextual information.
Discussion
OX1R is abundantly expressed in LC-NA neurons. Although there is one report suggesting that OX1R signaling is involved in depression-like behavior (Scott et al., 2011), physiological roles of OX1R in the LC are hardly known.
Several studies have implicated LC-NA neurons in establishing fear memory. For instance, activity of LC-NA neurons increased after a fear-conditioning test (Ishida et al., 2002). NA release in the LA increased with presentation of stressful stimuli (Galvez et al., 1996). Involvement of the NA system in fear and anxiety has also been shown clinically, because β-adrenergic blockade has been shown to be effective for treating patients with post-traumatic stress disorder (Vaiva et al., 2003).
Clinical investigation suggests that human narcolepsy–cataplexy, a sleep–wake disorder caused by a specific loss of hypothalamic orexin, is associated with reduced amygdala activity during aversive conditioning (Ponz et al., 2010), suggesting that the orexin system is involved in the regulation of amygdala function. Recent observations also showed that activation of orexin neurons is necessary for developing a panic-prone state in an animal model, and either silencing the hypothalamic orexin gene with RNA interference or a systemic OX1R antagonist blocks the panic responses. Human subjects with panic anxiety have elevated level of orexin A in the CSF compared with subjects without panic anxiety (Johnson et al., 2010). These findings suggest that OX1R in the LC is involved in anxiety and fear. Supporting this hypothesis, a recent paper suggested that orexin receptors contribute to fear-conditioned startle reactions in the rat, using a dual orexin receptor antagonist, almorexant (Steiner et al., 2012).
Considering these observations, we hypothesized that orexin neurons regulate LC-NA neurons in fearful condition, and this pathway might play a role in establishing fear memory. To evaluate this hypothesis, we examined Ox1r−/− mice in cued and contextual fear-conditioning tests. Ox1r−/− mice displayed significant impairment of evoked freezing behavior, that is, behavioral expression of fear, in response to cued and contextual fear stimuli, whereas Ox2r−/− mice showed reduced freezing response to a contextual stimulus only (Figs. 1, 2).
Contrary to our initial hypothesis that OX1R in the LC might play an important role in acquisition and consolidation of fear-related memories, freezing time was already substantially decreased in Ox1r−/− mice in the conditioning period of both cued and contextual fear-conditioning paradigms (Figs. 1B, 2B). This suggests that OX1R signaling is involved in presentation of freezing behavior itself. However, while wild-type mice showed increased expression of fear in the test compared with conditioning session, the Ox1r−/− mice showed a smaller increase across both phases (Fig. 2B,C). This suggests that Ox1r−/− mice have deficits in the fear memory consolidation process. Also, Fos expression after the test sessions was lower in Ox1r−/− mice (Fig. 3D,F). These findings imply two possibilities: (1) OX1R may play an important role in expression of fear itself or (2) OX1R may play roles in both expression of fear and formation of fear-related memory.
To test the latter possibility, we next examined the contribution of OX1R in LC-NA neurons by expressing OX1R specifically in LC-NA neurons in Ox1r−/− mice. We specifically expressed OX1R in both sides of the LC in Ox1r−/− mice by AAV-mediated gene transfer. We found no difference in freezing behavior in the OX1R-restored and control (ChR2-expressed) groups in the conditioning sessions in both cued and contextual fear conditioning (Fig. 4C,F). This suggests that the mechanisms of behavioral responses to unconditioned threats evoked by sensory cues do not depend on OX1R in LC-NA neurons, but rather involve OX1R in other brain regions. LeDoux (2012) suggested that the fear response to electric shock involves sensory transmission to the LA through circuitry involving the accessory basal amygdala, ventromedial hypothalamus, premammillary nucleus of the hypothalamus, and dorsal periaqueductal gray. The LC is not involved in this circuit, which is consistent with our observation that restoration of OX1R in the LC did not affect freezing in the conditioning period.
In stark contrast, we found that restoration of OX1R in LC-NA neurons significantly increased freezing time in the test session of the cued fear-conditioning paradigm compared with that in the ChR2-expressing group (Fig. 4D,E). Furthermore, we found a group of mice in which virus injection was not successful (in which expression of OX1R-GFP in LC-NA neurons was <10%), which did not show any significant difference compared with the ChR2-injected group in the cued test (16.77 ± 5.24 and 28.77 ± 9.61% for failed injection group and ChR2 injection group, n = 9 and 7, respectively, t = 165, p = 0.2636).
These findings suggest that OX1R in LC-NA neurons plays a prominent role in the consolidation of cued fear memory. Furthermore, we found obvious differences in the number of Fos-positive TH neurons in the LC after the cued or contextual training sessions (Fig. 3). This further supports our hypothesis that activation of LC-NA neurons through OX1R might play an important role in the consolidation of fear memory after training. These results are consistent with a former study showing that the reconsolidation process of auditory cue-conditioned fear requires NA signaling via the β-adrenergic receptor (Dębiec et al., 2011) and implies that this mechanism requires orexinergic modulation through OX1R.
We also found that the sole expression of OX1R in LC-NA neurons did not restore freezing behavior in the contextual fear test (Fig. 4F,G), suggesting that OX1R-mediated activation of LC-NA neurons is not sufficient to restore the establishment of contextual fear memory. This hypothesis is further supported by our observation that rescue of OX1R in LC-NA neurons in Ox1r−/− mice normalized activation of the LA after the cued test, but not after the contextual test (Fig. 6). Although rescue of OX1R in LC-NA neurons increased the activation of LC-NA neurons after the context test, it was not sufficient to rescue amygdala activation. This suggests that other OX1R-mediated pathways might play significant roles in the activation of the amygdala in a fearful context.
Our present study suggests an important role of OX1R in cued fear memory. Previously, LeDoux et al. (1988) excluded a role of the lateral hypothalamus in cued fear learning, based on lesion experiments in rats. In contrast, a study showed that an orexin-specific neurotoxin-induced lesion of the perifornical hypothalamus led to impairment of the behavioral response in contextual fear conditioning, suggesting that orexin neurons play an important role in this function (Furlong and Carrive, 2007). These differences might stem from differences in animal species, experimental paradigm, and procedure to disrupt the lateral hypothalamus. Our present data clearly suggest that the orexin system may modulate the formation of fear memory through activation of LC-NA neurons.
Recently, the effects of almorexant, a dual orexin receptor antagonist, on contextual fear memory were reported. Almorexant did not reduce freezing, and nor did it significantly reduce the associated USVs in rats (Furlong et al., 2009). This suggests that acute blockade of orexin receptors does not affect contextual fear memory. The difference between this report and our present findings that both Ox1r−/− and Ox2r−/− mice showed reduced freezing in the contextual fear test might stem from the species difference and/or methodological difference, i.e., acute pharmacological blockade versus genetic modification and/or monitoring USVs versus freezing responses. However, in another report, almorexant was reported to decrease the fear response to cued fear to a light CS (Steiner et al., 2012). Consistently, our present study also suggests that OX1R in the LC plays an important role in cued fear conditioning. This result helps explain the dissociation between the effects of orexin receptor blockade on contextual and explicit cued fear. Both acute pharmacological blockade of OX1R and genetic disruption of the Ox1r gene impaired freezing in response to cued fear. Likewise, focal expression of OX1R in LC-NA neurons increased freezing behavior to a level comparable to that of wild-type in cued fear testing, but did not affect freezing in response to contextual fear. These results are consistent with the reports that showed lack of an effect of almorexant on contextual fear conditioning versus potent effects on fear conditioning to CS (Furlong et al., 2009; Steiner et al., 2012).
We found a prominent role of OX1R in cued fear conditioning, while most other peptides have been shown to be implicated in contextual fear conditioning and thus may play a role in contextual cue processing rather than in processing of fear conditioning per se. Our results also suggest that OX1R expressed in several regions of the brain plays different roles in fear-related behavior and memory through independent mechanisms. Especially, the orexin system is involved in the consolidation of cue-dependent fear memory via OX1R expressed in NA neurons in the LC. In addition, OX2R may also be involved in establishing contextual fear memory, suggesting a further complex mechanism involving the hippocampus or other OX2R-expressing regions. In conclusion, our findings show that the mechanism of establishing fear memory critically involves the orexin system. These findings might contribute to understanding of the complex neural mechanism in establishing fear memory.
Footnotes
This work was funded primarily by the government of Japan through its “Funding Program for Next Generation of World-leading Researchers” (grant to T.S.). PRSx8 was provided by Dr. Kwang-soo Kim. We thank Dr. Wendy Gray for reading this manuscript.
- Correspondence should be addressed to Dr. Takeshi Sakurai, Department of Molecular Neuroscience and Integrative Physiology, Faculty of Medicine, Kanazawa University, Kanazawa, Ishikawa 920-8640, Japan. tsakurai{at}med.kanazawa-u.ac.jp or takeshi.sakurai{at}gmail.com